產品名稱：Chagas (Trypanosoma cruzi) IgG ELISA
產    地：Demeditec 
產品貨號：DENO0114
產品規格：96 Tests
產品說明：
Special remarks:
INTENDED USE
The Demeditec Chagas (Trypanosoma cruzi) IgG-ELISA is intended for the qualitative determination of IgG class antibodies against Trypanosoma cruzi in human serum or plasma (citrate).
INTRODUCTION
Chagas’ disease occurs in Middle and South America. It is an infectious disease transmitted to humans through the bite wound caused by an infected bug of the family reduviidae. The infection is caused by Trypanosoma cruzi a unicellular parasite. The infection passes through different phases and causes an often chronic disease. 4 to 5 million people in South America are suffering from it. People living under poor conditions are mainly jeopardized. Up to 10 % of all infections are fatal; babies and neonates have a special risk.
The infection is transmitted to humans by different bug species of the family reduviidae. The parasite does not enter the human body with the bit of the bug. Trypanosoma cruzi lives in faeces of the bug and invades into humans by skin wounds. Newborns are at risk by infection in utero. An infection via blood transfusion is also possible.
1-2% of all infected people show symptoms after an incubation time of one to four weeks. Children up to 15 years old are mainly affected. The disease passes through three different phases.
During acute phase fever, diarrhoea, gripes, swollen lymph nodes and swelling of the whole body appears. Especially in neonates and infants inflammation of heart or brain are possible. The acute phase lasts for ca. 4 weeks. The acute Chagas disease is mostly a disease of children. In many cases the disease is healed up.
The following latency period is characterized by lack of symptoms for most of the patients. Occasionally a weakening of the immune system takes place. This phase can last several years. 10 to 20 % of infected people reach the chronic phase. Different inner organs like heart, intestinal tract or neuronal system can be affected. Patients often die be sudden cardiac death or as the result of a chronic heart insufficiency. The prognosis depends upon the degree of heart variance.
A  variety  of  diagnostic  methods  have  been  used,  but detection  of  antibodies  to  T.  cruzi  antigens  remains the  strongest  method  to diagnose infection.
上海玉博生物技術有限公司在為生命科學領域提供豐富的產品與信息資源方面處于****地位，公司提供的產品涵蓋了二十多個國家近五十萬種產品，而且產品的數量與信息在不斷的增長和更新，公司提供的產品能夠使生命科學工作者加快對生物化學，分子生物學，細胞生物學以及蛋白質組學研究的認知，以及分子診斷和臨床醫學領域的應用。

產品留言

標題

聯系人

聯系電話

內容

驗證碼

點擊換一張

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發送信息!
2.如有必要,請您留下您的詳細聯系方式!